Business
BCX: Pioneering stem cell therapies for pets, with proven efficacy and major market expansion plans
BCX: Pioneering stem cell therapies for pets, with proven efficacy and major market expansion plans
About this update from Bioceltix Sa
Focuses on allogeneic stem cell therapies for companion animals, with clinical success in canine atopic dermatitis and osteoarthritis. Expanding GMP manufacturing, advancing regulatory submissions, and developing innovative biologics, the company targets a rapidly growing veterinary therapeutics market.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.